| abstract |
There is provided a compound of formula I, or a pharmaceutically acceptable enantiomer, salt or solvate thereof. (I) The invention also relates to the use of a compound of formula I as a TDO2 inhibitor. The invention also relates to the use of compounds of formula I for the treatment and / or prevention of cancer, neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression, and obesity. The present invention also relates to a process for the preparation of compounds of formula (I). |